What Is Informed Consent in a Clinical Trial?

Informed consent often gets pictured as a single moment — signing a form. In reality, it's a process that starts before you make a decision and continues for as long as you're part of a trial.

Before you're asked to decide anything, the research team walks you through what the trial actually involves. That conversation is meant to give you a full picture, not just a summary.

During informed consent, you should hear clear information about:

• The purpose of the trial and what it's trying to learn.
• The procedures and tests involved, and what a typical visit or cycle might look like.
• Possible risks and possible benefits of taking part.
• All of your treatment options, including ones outside the trial.
• Details about the specific treatments or tests being studied.

This isn't a one-way lecture. You have the right to ask questions at any point, and the team should be willing to answer them in a way that makes sense to you.

Federal rules at 45 CFR 46.116 set the floor. Consent has to begin with a short summary of the key information. That summary must help you see why a person might want to take part, and why a person might not. The rule also says the rest cannot be a pile of isolated facts. It has to be organized so you can follow it.

The required elements include:

• A statement that this is research. Why it is being done, how long you would take part, what will happen, and which procedures are experimental.
• Any risks or discomforts that can reasonably be foreseen.
• Any benefits that can reasonably be expected, to you or to others.
• Other treatments that might help you instead.
• How private your records will be kept.
• For research with more than minimal risk, whether payment or medical care is available if you are injured, and where to learn more.
• Whom to contact with questions about the research, about your rights, and about a research-related injury.
• That taking part is voluntary. That saying no costs you nothing you were otherwise entitled to, and that you may stop at any time.

The information must be in language you can understand. You must also get a real chance to discuss it, under conditions that keep pressure low.

Some items appear only when they apply. These include risks that cannot yet be foreseen, and the situations in which the researchers may end your part in the study without your agreement. They also include any extra costs you would face, what withdrawing would involve, and roughly how many people are in the study. Ask which of these are in your form.

One rule is worth knowing before you sign. Under 45 CFR 46.116(a)(6), no consent form may contain exculpatory language. In plain terms, it may not ask you to waive your legal rights, or appear to. And it may not release the researcher, the sponsor, or the hospital from liability for negligence.

If a form reads that way to you, say so before you sign. That is not a negotiating position. It is a rule.

Informed consent comes with a set of protections that stay with you the whole time you're considering, and participating in, a trial:

• The right to ask questions before deciding.
• The right to take part if you choose to.
• The right to leave the trial at any time — including after you've already signed the consent form.
• The right to hear and read the information in a language you understand.

None of these rights expire once you sign paperwork. If you change your mind a week, a month, or a year into a trial, you're allowed to stop.

After your conversation with the research team, you'll receive a written consent form. It lays out everything that was discussed — purpose, procedures, risks, benefits, and your other options — so you can review it on your own time before deciding. If you agree to take part, you sign it.

Signing the form isn't the end of the conversation, though. As a trial continues, new information sometimes comes to light — about side effects, results, or anything else relevant to your decision to stay in the study. When that happens, the research team is expected to keep you informed, so you can decide whether you still want to continue.

Children under 18 aren't able to give informed consent on their own, since consent legally requires a certain level of understanding and independence. Instead, children may be asked to give assent, meaning they agree to take part, or they may dissent, meaning they decline. Depending on their age and understanding, children as young as 7 may be asked whether they assent or dissent, alongside a parent or guardian who provides consent on their behalf.

This approach respects a child's voice in the decision while still relying on a parent or guardian to formally consent.

Assent is not always required by law, though an institutional review board may require it. Usually both parents must give permission. There are exceptions. They apply when a parent has died, is unknown, is not reasonably available, or is not competent. They also apply when one parent has sole legal custody.

Informed consent works best as a two-way conversation. If anything about a trial's purpose, procedures, risks, or your other options isn't clear, that's exactly what the informed consent process is there for — so don't hesitate to ask until you feel you understand what you'd be agreeing to.

For who reviews a study and watches it while it runs, see your safety in a clinical trial.

• National Cancer Institute — Safety in Clinical Trials
• 45 CFR 46.116 — General requirements for informed consent (govinfo)